The therapy, dubbed OST-HER2, uses a HER2-bioengineered form of the bacteria Listeria monocytogenes to trigger an immune ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.
Verywell Health on MSN2d
17 Important Resources for Someone Who Has Metastatic Breast CancerMedically reviewed by Marla Anderson, MD The first signs of metastatic breast cancer depend on where the cancer spreads from ...
In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...
British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...
A recent study has highlighted a significant increase in the use of inpatient palliative care among metastatic testicular cancer patients undergoing critical care therapy between 2008 and 2019. Read ...
Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...
News Medical on MSN5d
Pancreatic cancer insights: How pORG classifications predict survival and guide treatmentResearchers identify distinct molecular and immune profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma.
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback